United States · Growth startup
5 rounds we have observed, with the 11 investors named in them. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.
Funding summaryUpdated 26 Oct 2026
$73Mraised across 5 rounds since 2003, from 5 sources
Each circle is a round, placed by date and sized by amount. The line above is the running total.
From a historical funding recordSEC filing: $17M sold, first sale May 2012
Mitsubishi UFJ Capital
Sofinnova Investments
5AM Ventures
MPM Capital
GBS Ventures
Sanofi-Genzyme BioVenturesFrom a historical funding record
Sofinnova Investments5AM VenturesMPM CapitalFrom a historical funding record
The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.
Sofinnova InvestmentsAlloy Ventures5AM VenturesMPM CapitalSingapore Bio-InnovationsMitsubishi UFJ CapitalGBS VenturesSanofi-Genzyme BioVenturesLotus BioScience Ventures
Fidelity Management and Research CompanyFrom historical deal records. Wrong? Tell us.
Missing a round, or an investor who was in one? Tell us.
KaloBios Pharmaceuticals's investors include Sofinnova Investments, Alloy Ventures, 5AM Ventures, MPM Capital and Singapore Bio-Innovations, and 6 more on record.
KaloBios Pharmaceuticals has raised $73M across 5 rounds since 2003.
KaloBios Pharmaceuticals's most recent round was a Growth of $17M in Apr 2012.
KaloBios Pharmaceuticals's largest round on record is $20M (Series D), in Sept 2008.
KaloBios Pharmaceuticals's first round on record, in Jun 2003, was backed by Sofinnova Investments and Alloy Ventures.
KaloBios Pharmaceuticals's latest named round is a Growth, in Apr 2012.
KaloBios Pharmaceuticals is based in the United States.
Search every investor by what they have actually funded, then narrow to your stage and market. Free.
United States ·